What does the latest science say about the use of GLP-1 meds to treat obesity in people without diabetes?A review of 26 ...

Over her three-decade career, weight management physician Dr. Sarah Ro has seen hundreds of patients. Many of them are on ...

Metsera has linked its GLP-1 drug candidate to weight loss of up to 11.3% after 12 weeks, encouraging the biotech to use some ...

A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic.

How GLP-1 therapies could help build a healthier, more productive workforce—and what that would mean for how we live together ...

Surgeons are collaborating with obesity medicine physicians, turning to GLP-1s to help high BMI patients qualify for surgery.

With 13 states offering coverage, it’s already a $3.9 billion cost. Some state officials say reducing obesity will save programs money in the long run.

As a reader of the news, you already know that West Virginia in most years remains in last place or near last place for ...

San Francisco 49ers' quarterback Josh Dobbs finds a wide open fullback in Kyle Juszczyk on a throwback pass and Juszczyk ...

While obesity product sales will be driving the boon in 2025, industry experts are also eyeing promising new launches in ...

Obese mice whose fat cells were genetically altered to produce an increased amount of the glucose-dependent insulinotropic ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...